How is MT-2 (Melanotan II) administered?
This describes how MT-2 (Melanotan II) is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a daily loading → 2-3x weekly maintenance schedule, generally over loading 1-2 wks, then maintenance. Specific dosing is individual and beyond general information, and human evidence for MT-2 (Melanotan II) is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: Daily loading → 2-3x weekly maintenance
- Cycle length: Loading 1-2 wks, then maintenance
- Half-life: ~30 minutes
References
- Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study — Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME — Life Sciences, 1996;58(20):1777-84
- Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'? — Langan EA, Nie Z, Rhodes LE — British Journal of Dermatology, 2010;163(3):451-5
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on MT-2 (Melanotan II)
Full MT-2 (Melanotan II) breakdownMT-2 (Melanotan II) what it's used forMT-2 (Melanotan II) side effectsMT-2 (Melanotan II) mistakes to avoidMT-2 (Melanotan II) who should avoid itMT-2 (Melanotan II) half-lifeMT-2 (Melanotan II) how long to workMT-2 (Melanotan II) legal statusMT-2 (Melanotan II) how it worksmt 1 vs mt 2Ask the AI Coach
Last updated 2026-06-15.